Precise structural analysis of O-linked oligosaccharides in human serum

Glycobiology

Volumn 24, Issue 6, 2014, Pages 542-553

  Yabu, Masahiko ^a   Korekane, Hiroaki ^b   Miyamoto, Yasuhide ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b RIKEN   (Japan)

Author keywords

mass spectrometry; O glycan; serum; two dimensional mapping

Indexed keywords

AMINOPYRIDINE; BETA 1,4 GALACTOSIDASE; BETA N ACETYLHEXOSAMINIDASE; CA 19-9 ANTIGEN; GELATINASE B; O LINKED OLIGOSACCHARIDE; OLIGOSACCHARIDE; SIALIC ACID DERIVATIVE; SIALYL LEWIS X ANTIGEN; TN ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; DISIALOSYL GALACTOSYL GLOBOSIDE; GANGLIOSIDE; POLYSACCHARIDE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BLOOD GROUP A; BLOOD LEVEL; CHEMICAL STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METHANOLYSIS; NONHUMAN; O LINKED OLIGOSACCHARIDE BLOOD LEVEL; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; GLYCOSYLATION; NEOPLASM; PATHOLOGY;

GANGLIOSIDES; GLYCOSYLATION; HUMANS; NEOPLASMS; OLIGOSACCHARIDES; POLYSACCHARIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84899787021     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu022     Document Type: Article

References (39)

1. Brockhausen I. 1999. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta. 1473(1):67-95.
2. Canney PA, Moore M, Wilkinson PM, James RD. 1984. Ovarian cancer antigen CA125: A prospective clinical assessment of its role as a tumour marker. Br J Cancer. 50(6):765-769.
3. Chia D, Terasaki PI, Suyama N, Galton J, Hirota M, Katz D. 1985. Use of monoclonal antibodies to sialylated Lewisx and sialylated Lewisa for serological tests of cancer. Cancer Res. 45(1):435-437.
4. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, et al. 1983. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem. 29(3):549-552.
5. Fukuda M. 1996. Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56(10):2237-2244.
6. Hakomori S. 1989. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 52:257-331.
7. Hakomori S. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56(23):5309-5318.
8. Hakomori S. 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA. 99(16):10231-10233.
9. Hemmerich S, Leffler H, Rosen SD. 1995. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J Biol Chem. 270 (20):12035-12047.
10. Ikeda N, Eguchi H, Nishihara S, Narimatsu H, Kannagi R, Irimura T, Ohta M, Matsuda H, Taniguchi N, Honke K. 2001. A remodeling system of the 3′-sulfo-Lewis a and 3′-sulfo-Lewis x epitopes. J Biol Chem. 276 (42):38588-38594.
11. Iwatsuka K, Watanabe S, Kinoshita M, Kamisue K, Yamada K, Hayakawa T, Suzuki T, Kakehi K. 2013. Free glycans derived from glycoproteins present in human sera. J Chromatogr B Analyt Technol Biomed Life Sci. 928 (2013):16-21.
12. Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Hiraiwa N, Fukuda Y, Inamoto T, Hakomori S, et al. 1986. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res. 46(5):2619-2626.
13. Kim YJ, Varki A. 1997. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J. 14(5):569-576.
14. Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, et al. 2007. A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics. 6(1):43-55.
15. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S. 1988. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 48(8):2214-2220.
16. Korekane H, Tsuji S, Noura S, Ohue M, Sasaki Y, Imaoka S, Miyamoto Y. 2007. Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis. Anal Biochem. 364(1):37-50.
17. Kozak RP, Royle L, Gardner RA, Fernandes DL, Wuhrer M. 2012. Suppression of peeling during the release of O-glycans by hydrazinolysis. Anal Biochem. 423(1):119-128.
18. Lan MS, Finn OJ, Fernsten PD, Metzgar RS. 1985. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res. 45(1):305-310.
19. Lau KS, Dennis JW. 2008. N-Glycans in cancer progression. Glycobiology. 18 (10):750-760.
20. Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. 2008. Glycomics analysis of serum: A potential new biomarker for ovarian cancer? Int J Gynecol Cancer. 18(3):470-475.
21. Lloyd KO, Yin BW, Kudryashov V. 1997. Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): Identification as a mucin-type molecule. Int J Cancer. 71(5):842-850.
22. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. 1983. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 43 (11):5489-5492.
23. Misonou Y, Shida K, Korekane H, Seki Y, Noura S, Ohue M, Miyamoto Y. 2009. Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: Elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. J Proteome Res. 8(6):2990-3005.
24. Motoo Y, Kawakami H, Watanabe H, Satomura Y, Ohta H, Okai T, Makino H, Toya D, Sawabu N. 1991. Serum sialyl-Tn antigen levels in patients with digestive cancers. Oncology. 48(4):321-326.
25. Murakami T, Natsuka S, Nakakita S, Hase S. 2007. Structure determination of a sulfated N-glycans, candidate for a precursor of the selectin ligand in bovine lung. Glycoconj J. 24(4-5):195-206.
26. Narimatsu H, Iwasaki H, Nakayama F, Ikehara Y, Kudo T, Nishihara S, Sugano K, Okura H, Fujita S, Hirohashi S. 1998. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res. 58(3):512-518.
27. Natsuka S, Hase S. 1998. Analysis of N-and O-glycans by pyridylamination. Methods Mol Biol. 76:101-113.
28. Natsuka S, Hirohata Y, Nakakita S, Sumiyoshi W, Hase S. 2011. Structural analysis of N-glycans of the planarian Dugesia japonica. FEBS J. 278(3): 452-460.
29. Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakomori S, Itzkowitz SH. 1995. Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res. 55(9):1869-1874.
30. Ono M, Hakomori S. 2004. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J. 20(1):71-78.
31. Pierce-Cretel A, Decottignies JP, Wieruszeski JM, Strecker G, Montreuil J, Spik G. 1989. Primary structure of twenty three neutral and monosialylated oligosaccharides O-glycosidically linked to the human secretory immunoglobulin A hinge region determined by a combination of permethylation analysis and 400-MHz 1H-NMR spectroscopy. Eur J Biochem. 182(2):457-476.
32. Podolsky DK. 1985. Oligosaccharide structures of human colonic mucin. J Biol Chem. 260(14):8262-8271.
33. Royle L, Mattu TS, Hart E, Langridge JI, Merry AH, Murphy N, Harvey DJ, Dwek RA, Rudd PM. 2002. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem. 304(1):70-90.
34. Shida K, Misonou Y, Korekane H, Seki Y, Noura S, Ohue M, Honke K, Miyamoto Y. 2009. Unusual accumulation of sulfated glycosphingolipids in colon cancer cells. Glycobiology. 19(9):1018-1033.
35. Storr SJ, Royle L, Chapman CJ, Hamid UM, Robertson JF, Murray A, Dwek RA, Rudd PM. 2008. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology. 18(6):456-462.
36. Takasaki H, Uchida E, Tempero MA, Burnett DA, Metzgar RS, Pour PM. 1988. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res. 48(6):1435-1438.
37. Wada Y, Kadoya M, Okamoto N. 2012. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient. Glycobiology. 22(8):1140-1144.
38. Yabu M, Korekane H, Takahashi H, Ohigashi H, Ishikawa O, Miyamoto Y. 2013. Accumulation of free Neu5Ac-containing complex-type N-glycans in human pancreatic cancers. Glycoconj J. 30(3):247-256.
39. Yamada K, Hyodo S, Kinoshita M, Hayakawa T, Kakehi K. 2010. Hyphenated technique for releasing and MALDI MS analysis of O-glycans in mucin-type glycoprotein samples. Anal Chem. 82(17):7436-7443.